Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001104659-22-072188

Options or other derivatives

  • Director acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Seehra Jasbir Director 2022-06-15 Grant or award · Stock Options (Right to Buy) +20,000 20,000 D: show line 1 in the form
Loading xslF345X03/tm2218714-6_4seq1.xml…